MEDICINOVA INC's ticker is MNOV and the CUSIP is 58468P206. A total of 59 filers reported holding MEDICINOVA INC in Q4 2020. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $300,000 | -8.0% | 57,340 | -4.6% | 0.00% | 0.0% |
| Q2 2020 | $326,000 | +9.8% | 60,114 | -24.6% | 0.00% | -20.0% |
| Q1 2020 | $297,000 | -50.5% | 79,707 | -10.4% | 0.01% | 0.0% |
| Q4 2019 | $600,000 | -12.8% | 89,001 | +3.0% | 0.01% | 0.0% |
| Q3 2019 | $688,000 | -20.7% | 86,432 | -4.1% | 0.01% | -16.7% |
| Q2 2019 | $868,000 | +3.0% | 90,132 | -11.5% | 0.01% | 0.0% |
| Q1 2019 | $843,000 | +6.6% | 101,861 | +5.2% | 0.01% | 0.0% |
| Q4 2018 | $791,000 | -14.6% | 96,784 | +30.6% | 0.01% | 0.0% |
| Q3 2018 | $926,000 | +94.9% | 74,109 | +24.2% | 0.01% | +100.0% |
| Q2 2018 | $475,000 | -13.6% | 59,686 | +11.0% | 0.00% | -25.0% |
| Q1 2018 | $550,000 | +112.4% | 53,772 | +34.4% | 0.00% | +100.0% |
| Q4 2017 | $259,000 | -21.3% | 40,004 | -9.0% | 0.00% | -33.3% |
| Q3 2016 | $329,000 | -3.8% | 43,944 | -3.0% | 0.00% | 0.0% |
| Q2 2016 | $342,000 | – | 45,316 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 1,105,941 | $2,388,833 | 1.38% |
| Capricorn Fund Managers Ltd | 25,379 | $54,819 | 0.02% |
| Blankinship & Foster, LLC | 15,700 | $33,912 | 0.02% |
| WealthTrust Axiom LLC | 12,500 | $27,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 145,147 | $313,518 | 0.01% |
| Ergoteles LLC | 69,240 | $149,558 | 0.01% |
| HRT FINANCIAL LP | 163,819 | $353 | 0.00% |
| CITIGROUP INC | 447,957 | $967,587 | 0.00% |
| Tower Research Capital LLC (TRC) | 20,529 | $44 | 0.00% |
| Schonfeld Strategic Advisors LLC | 43,300 | $93,528 | 0.00% |